CClinicalTrials.gg
CompletedNCT07512492Updated Apr 6, 2026

Combination Effect of Proprioceptive Training and Transcranial Magnetic Stimulation on Selected Gait Kinematic Parameters in Stroke Patients

An interventional study of Transcranial Magnetic Stimulation and selected physical therapy program in Transcranial Magnetic Stimulation, Stroke and Gait Disorders, Neurologic, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 50 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Dec 2024, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
50 Years to 60 Years
Sex
All
01

Study summary

this study was done to investigate the Combination effect of proprioceptive training and transcranial magnetic stimulation on selected gait kinematic parameters in stroke patients.

Read the detailed description

After a stroke, mobility is influenced by the central nervous system and peripheral neuromuscular and sensory systems. Effective standing and walking require managing body support against gravity and generating propulsion. Gait deficits in stroke survivors often arise from neural, sensory, muscular issues, and coordination problems, leading to movement disorders like spasticity and ataxia that hinder motor control and gait performance. Typically, stroke patients display reduced gait velocity and abnormal kinematics, marked by asymmetries and decreased weight bearing on the affected limb. Research indicates that combining high-frequency Transcranial magnetic stimulation with task-oriented mirror therapy enhances motor function more effectively than Transcranial magnetic stimulation alone, yielding improvements in hand function and cortical excitability. Similar findings for subacute stroke patients highlight the benefits of integrating action observation with Transcranial magnetic stimulation for better upper limb function.

02

Conditions studied

  • Transcranial Magnetic Stimulation
  • Stroke
  • Gait Disorders, Neurologic
  • Proprioceptive Training
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Thirty patients with stroke from both sexes.

2) Age will range from 50 to 60 years old.

3) Duration of stroke ≥ 6 months.

4) Spasticity of the lower limb ranges from 1+ to 2 according to modified ashworth scale

5) The patients able to walk with or without assistive device.

6) Body mass index is less than 30 kg/m2.

7) Patients with sufficient cognitive abilities that enables them to understand and follow instructions (Mini-Mental State Examination scale >24).

Exclusion criteria

Exclusion Criteria:

  1. Previous history of any other neurological disorder
  2. Recurrent stroke.
  3. Vestibular deficits.
  4. Cognitive impairment (a score less than 24 according to mini mental state examination).

5- Cardiac pacemaker

6- Metallic Implants.

7- Aphasia, deafness or blindness

7. Deformities or contractures of the lower limbs

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Transcranial Magnetic Stimulation and proprioceptive training

    this group received a transcranial magnetic stimulation session for 20 min ,15 min of strengthening of lower limb and bridging exercises, and passive stretching for lower limb, and adding five exercises of proprioceptive training post Transcranial Magnetic Stimulation session for 15 min.

    Device: Transcranial Magnetic Stimulation · Other: selected physical therapy program · Other: proprioceptive training

  • Active comparator
    Transcranial Magnetic Stimulation only

    this group received only Rtms session for 20 min and 30 min of strengthening of lower limb and bridging exercises and passive stretching for lower limb

    Device: Transcranial Magnetic Stimulation · Other: selected physical therapy program

Interventions

  • DeviceTranscranial Magnetic Stimulation

    Transcranial Magnetic Stimulation (TMS) is a non-invasive method that uses magnetic fields to stimulate brain nerve cells through figure-eight or circular coils with strengths of 1.5 to 3.0 Tesla. The TMS pulses, lasting about 100 microseconds, can be adjusted to induce excitatory or inhibitory responses, with a focus on specific brain regions. Although Transcranial Magnetic Stimulation is safe with mild side effects, its efficacy declines with depth. It is commonly used in treating depression and anxiety, as well as in cognitive neuroscience research, often employing a protocol of high-frequency Transcranial Magnetic Stimulation (≥5 Hertz) for 20 minutes on the lower limb region of the bilateral cerebrum at 90% of the motor threshold.

  • Otherselected physical therapy program

    The program provides a set of exercises focused on improving ankle and knee movements, building muscle strength, and increasing the range of motion. It details eight activities: Ankle Movements for controlling foot actions; Active Knee Extension to strengthen the quadriceps; Gluteus maximus Squeezes for gluteal muscle enhancement; Inner Range Quadriceps involving a towel for knee support; Bridging to elevate the pelvis; a Passive Stretching Program for gentle knee stretches; Trunk Rotation to improve mobility; and Ankle Flexion to bend the ankle without foot rotation. The exercises are designed for gradual progression based on patient tolerance.

  • Otherproprioceptive training

    The program outlines techniques for enhancing patient mobility and balance through various exercises. In modified plantigrade, patients practice stepping forward and backward while weight shifting, facilitated by a therapist's manual contact on the pelvis. Activities with footprint markers encourage active stepping, while resisted stepping involves pushing against elastic resistance. Utilizing a wobble board helps patients maintain balance and perform self-initiated tilts to improve stability. Prerequisite exercises for stair climbing, such as bridging and sit-to-stand transfers, include verbal cues to guide weight shifts and step placements, progressing from low to standard steps with therapist assistance as necessary.

06

What researchers measure

Primary outcomes

  1. Assessment of gait function using Dynamic Gait Index:

    For two groups a. Assessment of gait function using Dynamic Gait Index: Each item is scored on a 4-level ordinal scale. * Grade 3 = normal performance * Grade 2 = minimal impairment, * Grade 1 = moderate impairment, * Grade 0 = severe impairment. The maximum possible score is 24 points. The Dynamic gait index can be administered in 10 minutes and requires a box, 2 cones, stairs and twenty-foot walkway.

    Time frame: At baseline and after 6 weeks

Secondary outcomes

  1. Assessment of ankle range of motion

    To measure ankle angle during walking, a digital camera is set 1.5 m away from the subject at shoulder height. The testing involves having subjects maintain a standardized posture while moving naturally between two points, fifteen yards apart. Images and videos captured during this process are analyzed using Kinovea software for angle measurement.

    Time frame: At baseline and after 6 weeks

  2. Assessment of step length

    To measure step length during walking, a digital camera is set 1.5 m away from the subject at shoulder height. The testing involves having subjects maintain a standardized posture while moving naturally between two points, fifteen yards apart. Images and videos captured during this process are analyzed using Kinovea software for angle measurement.

    Time frame: At baseline and after 6 weeks

  3. Assessment of step duration

    To measure step duration during walking, a digital camera is set 1.5 m away from the subject at shoulder height. The testing involves having subjects maintain a standardized posture while moving naturally between two points, fifteen yards apart. Images and videos captured during this process are analyzed using Kinovea software for angle measurement.

    Time frame: At baseline and after 6 weeks

  4. Assessment of cadence

    To measure cadence during walking, a digital camera is set 1.5 m away from the subject at shoulder height. The testing involves having subjects maintain a standardized posture while moving naturally between two points, fifteen yards apart. Images and videos captured during this process are analyzed using Kinovea software for angle measurement.

    Time frame: At baseline and after 6 weeks

07

Study locations

1 site
  • the Qasr El Eyni Hospitals and Private clinics.
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07512492
Lead sponsor
Cairo University
Responsible party
Mahmoud Alaa Shabaan (principal investigator, Cairo University) — Principal investigator
First posted
Apr 6, 2026
Start date
Dec 1, 2024
Primary completion
Aug 1, 2025
Completion
Oct 1, 2025
Last update
Apr 6, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion